GobblesGobbles

Recalled formula, three sick infants, multistate botulism probe

4 min readPublishes daily4 sourcesAI-written, source-linked. Learn moreOutbreak Watch summarizes public health reporting and official alerts. It is not medical advice; use CDC, WHO, local health authorities, or a clinician for personal health decisions.

3 infants with confirmed or suspected infant botulism have been reported from 3 states as of June 13, 2026.

Recalled formula, three sick infants, multistate botulism probe

The CDC and federal and state health officials are investigating a multistate outbreak of infant botulism linked to recalled powdered infant formula. As of June 13, 2026, 3 infants with confirmed or suspected botulism have been reported from 3 states: California, Pennsylvania, and Washington. Public health officials are interviewing caregivers about what the infants were fed in the month before they got sick. All reported feeding the infants Nara Organics infant formula โ€” and on June 13, 2026, Nara Organics recalled all Nara Organics Whole Milk Organic Infant Formula sold at Target retail stores, Target.com, and Nara.com.

Gobbles Gobble's Take: When every case points to the same product across multiple states, the recall is the headline โ€” and the interview log is what closes it. Source: Outbreak News Today


New Mexico's first plague fatality of 2026

New Mexico state health officials report a human plague fatality in a woman from Santa Fe County โ€” the first human plague case in the state this year. The New Mexico Department of Health has contacted the woman's contacts and will conduct an environmental assessment. The public-health framing here is classic plague, not movie-plague: a bacterial disease carried by rodents, found throughout much of the western United States, generally transmitted through the bites of infected fleas from wild rodents or household pets, and sometimes through direct contact with infected animals. People with plague in their lungs can also transmit it through coughing.

Gobbles Gobble's Take: One case is not a trend. It is, however, a firm reminder that "rare" and "gone" are not the same word. Source: Outbreak News Today


Ebola Bundibugyo is the global watch item

The CDC is responding to an Ebola outbreak in remote areas of the DRC and Uganda. As of June 8, 2026, there are no confirmed US cases and overall risk to the American public and travelers remains low. WHO and Africa CDC have called the outbreak serious and fast-moving. Reuters reported that WHO announced a $518 million six-month joint plan to support DRC and Uganda and help neighboring countries prepare through measures including enhanced border screening. Reuters also reported that commonly used Ebola tests initially failed to detect this strain โ€” contributing to testing challenges and delays.

Gobbles Gobble's Take: Low domestic risk is genuinely good news. It is not, however, a reason to thin the surveillance systems that are supposed to keep it that way. Source: David Kotok


Ebola Bundibugyo: ugly timing, messy politics

The Ebola Bundibugyo outbreak in the Democratic Republic of the Congo and Uganda has entered a more dangerous phase. Ebola does not spread like COVID, influenza, or measles โ€” it is not efficiently airborne, and people are not contagious before symptoms begin. But low risk is not the same as no risk, and it is not the same as a situation under control. A four-week detection gap between the onset of symptoms of the presumed index case on April 25, 2026, and laboratory confirmation on May 14 allowed the virus to spread silently before any response could begin. On May 17, 2026, WHO declared the outbreak a Public Health Emergency of International Concern.

Gobbles Gobble's Take: The virus is dangerous enough on its own. The detection gaps and policy brawls are the part nobody ordered. Source: Perplexity Search


In Case You Missed It

Yesterday's top stories:

Was this briefing useful?

One tap helps Gobbles learn what to cover more carefully.

Get Outbreak Watch in your inbox

Free daily briefing. No spam. Unsubscribe anytime.

See something wrong? Report an inaccuracy